According to Harvard Medical School, 13 million Americans suffer from thyroid disorders, and in more than 80% of cases, the problem is underactive thyroid gland i.e. Hypothyroidism. As thyroid hormone regulates body metabolism, its deficiency would lead to symptoms like tiredness, irregular heartbeat, impaired memory, weight gain, slow metabolism and others. The major cause of thyroid deficiency is autoimmunity in developed nations and most often iodine deficiency in developing countries. Almost one-third of the world's population belongs to the Asian and African region which is one of the prevalent regions for iodine deficiency which can lead to the chronic conditions such as congenital hypothyroidism or goiter further leading to thyroid cancer.Synthetic thyroxine is given as therapeutic for thyroid deficiency treatment by oral or intravenous route and most commonly used the drug is the levothyroxine oral sold by the brand names Synthroid, Levoxyl, Levothroid, Unithroid, Tirosint, Levo-T. Thyroid deficiency treatment market is continuously growing over the years by applying thyroid hormone replacement therapy. Thyroid deficiency treatment cost is also growing at the same pace with the increase in some patients with hypothyroidism.
Thyroid Deficiency Treatment Market: Region-wise Outlook
North America is the top marketplace for thyroid deficiency treatment because of number of patients. Western Europe is observed as the growing market with the increase in the number of patients than Eastern Europe. The amount of prescribed thyroid hormone used in England only is more than double over the last ten years. More than the developed countries, the developing countries like Asia-Pacific, China, Japan, Middle East and Africa will likely to show tremendous growth in the market in the future due to high prevalence of iodine deficiency, increasing cases of Goiter, the inabilityof in-depth diagnostic work-up, decrease diet and other factors.
Thyroid Deficiency Treatment Market: Key Players
Generic drugs with several brand names are being manufactured in different parts of the world. Some of the global key players in thyroid deficiency treatment market are Glaxo Smithkline Pharmaceuticals Ltd., Abbott Laboratories, Pfizer Inc., Mylan Pharmaceuticals Inc., Allergan, Genzyme Therapeutics and others.
Request Sample Report@ www.futuremarketinsights.com/reports/sample/rep-gb-3140/